clinical trial · NCT06207032
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Tempus AI·—·recruiting·n = 500
Cancer
brief summary
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
started
Jun 26, 2024
primary completion
Jun 1, 2029
completion
Jun 1, 2029
last updated
Feb 24, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol